Coronavirus Notebook: Middle Ground Pricing As Moderna Reaches 100m Dose US Agreement

Plus, Evidence Accelerator Finds No Benefit With HCQ

 
• By Pink Sheet Team
Coronavirus COVID-19 medical test vaccine research and development concept. Scientist in laboratory study and analyze scientific sample of Coronavirus antibody to produce drug treatment for COVID-19.
Moderna Reaches Initial US Vaccine Supply, Option Deal • Source: Shutterstock

More from Real-World Evidence

More from Clinical Trials